OKYO Pharma Ltd. Form 6-K Summary
Filing date: September 29, 2026. This Form 6-K reports an announcement by the foreign private issuer; it does not cover a financial reporting period.
Business context
OKYO Pharma said it would present and participate at upcoming ophthalmic conferences. The referenced announcement is identified as Exhibit 99.1, but its text is not included in the supplied filing content.
Financial results and changes
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics, and no comparison with a prior period.
Outlook, risks, and filing treatment
No financial guidance, detailed management commentary, risks, contingencies, or unusual items are provided in the supplied text. The announcement is furnished, not deemed filed for purposes of Exchange Act Section 18. The report is incorporated by reference into the company’s Form F-3 registration statement (No. 333-293145).
Investor facts to verify
- Review Exhibit 99.1 for the conference names, dates, presentation details, and any additional company disclosures.
- Consult the company’s financial filings for current financial results, liquidity, and risks; this 6-K does not provide them.